BUSINESS BRIEF
Established in 1983, a South-India based women’s healthcare and fertility hospital is a well-established, multi-specialty facility specialising in obstetrics, gynaecology, fertility care, and neonatal services. The hospital operates with 50+ beds and is equipped with advanced infrastructure, including an ART Centre offering IVF, ICSI and cryo-preservation, a fully functional NICU, minimally invasive surgery facilities, and advanced diagnostic services such as 3D and 4D ultrasound. The hospital is built on a wholly owned land amounting to 1,135 sq. yd. with the built-up area 29,904 sq. ft. The hospital has been credited with ISO 9001 for its quality practice.
The hospital is led by a highly experienced team of 20+ experienced doctors (MD/DNB/Fellowship-qualified) across women’s health, fertility, neonatal & surgical specialities having over two decades of clinical expertise. Over the decades, it has also earned the trust of a wide patient base, including several prominent public figures and their families, reflecting its longstanding credibility in women and child healthcare. The hospital maintains active empanelment with leading insurance providers, ensuring accessibility across patient segments, and continues to focus on operational excellence and sustained growth.
Business Divisions
- ART centre with full fledged facilities for IVF, ICSI & Cryo-preservation
- Outpatient Hysteroscopy unit
- High Dependency Unit
- Neonatal Intensive Care Unit - NICU
- Minimal Invasive Surgery Unit
- Colposcopy Unit
Products & Services
Women’s healthcare and fertility services
Proposal
Industry
Hospitals and Healthcare
Sub Industry
Hospitals and Extended Care
Nature of Business
B2C
Sector
Agriculture & Allied
Reason for sell-off
Retirement or Personal Reasons
Location
India
Region
Southern
Open For Dilution
100 % (Complete Buyout)
Top Customer
Deal Size
INR 55 - 60 Cr
Justification
Reason for decline in Revenue: Revenue moderated post-COVID as the promoters consciously reduced incremental working capital infusion, driven by succession considerations and a deliberate pause on aggressive marketing initiatives.
Business Operation Information
Financial Information |
2025 (in INR Cr) | 2024 (in INR Cr) | 2023 (in INR Cr) |
|---|---|---|---|
Sales |
7.54 | 8.88 | 8.94 |
EBITDA |
|||
PAT |